Clinical Trial: A Phase 1 Study of JADE101 in Healthy Participants

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07059312) titled 'A Phase 1 Study of JADE101 in Healthy Participants' on June 27.

Brief Summary: This is a Phase 1, first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE101 compared to placebo in healthy participants.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: JADE101

JADE101 is supplied as sterile solution to be administered by SC injection.

DRUG: Placebo

Placebo solution to be administered at a matching volume by SC injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jade Biosciences, Inc.

Pu...